Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic Cancer
Wungki Park, Akhil Chawla, Eileen M. O’Reilly
JAMA (2021) Vol. 326, Iss. 9, pp. 851-851
Open Access | Times Cited: 1104

Showing 1-25 of 1104 citing articles:

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Luis A. Rojas, Zachary Sethna, Kevin C. Soares, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 144-150
Open Access | Times Cited: 613
Neoadjuvant therapy for pancreatic cancer
Christoph Springfeld, Cristina R. Ferrone, Matthew H. G. Katz, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 318-337
Closed Access | Times Cited: 194
A faecal microbiota signature with high specificity for pancreatic cancer
Ece Kartal, Thomas Schmidt, Esther Molina‐Montes, et al.
Gut (2022) Vol. 71, Iss. 7, pp. 1359-1372
Open Access | Times Cited: 180
A one-pot isothermal Cas12-based assay for the sensitive detection of microRNAs
He Yan, Yunjie Wen, Zimu Tian, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 12, pp. 1583-1601
Open Access | Times Cited: 162
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A. Wainberg, Colin D. Weekes, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 531-542
Open Access | Times Cited: 71
The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients
Arsen Osipov, Ognjen Nikolic, Arkadiusz Gertych, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 299-314
Open Access | Times Cited: 29
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Marc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1859-1877
Closed Access | Times Cited: 26
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
Lingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 749-761
Closed Access | Times Cited: 23
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 22
Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer
Caili Xu, Xiting Huang, Qinchao Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117550-117550
Open Access | Times Cited: 15
KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma
Carter Norton, Matthew Shaw, Zachary Rubnitz, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2453588-e2453588
Open Access | Times Cited: 2
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients
Di Jin, Najeeb Ullah Khan, Wei Gu, et al.
Neoplasia (2025) Vol. 60, pp. 101129-101129
Closed Access | Times Cited: 2
Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis
Xuqing Shen, Yueyue Chen, Yingying Tang, et al.
Cell Reports Medicine (2025), pp. 101928-101928
Open Access | Times Cited: 1
Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and Meta-analysis of Latest Randomized Controlled Trials
Anna Ho Yin Chan, Yun Zhao, Hwee Leong Tan, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 1
Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes
Premila D. Leiphrakpam, Sanjib Chowdhury, Michelle Zhang, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access | Times Cited: 1
Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up
Derk C.F. Klatte, Bas Boekestijn, Martin N.J.M. Wasser, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 28, pp. 3267-3277
Open Access | Times Cited: 67
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Xinpeng Yin, Ruiyuan Xu, Jianlu Song, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1234-1256
Open Access | Times Cited: 61
The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
Shuangying Li, Liangliang Wang, Yuanyuan Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis
Kun Cai, Shiyu Chen, Changhao Zhu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 57
Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer
Libo Wang, Zaoqu Liu, Ruopeng Liang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 57
A Versatile 980 nm Absorbing Aggregation‐Induced Emission Luminogen for NIR‐II Imaging‐Guided Synergistic Photo‐Immunotherapy Against Advanced Pancreatic Cancer
Miao Wang, Dingyuan Yan, Meng Wang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 36
Closed Access | Times Cited: 48
Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
Xiang Zhang, Shangyou Zheng, Chonghui Hu, et al.
Oncogene (2022) Vol. 41, Iss. 16, pp. 2372-2389
Open Access | Times Cited: 46
Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity
Xu‐Feng Huang, Shujing Zhou, János Tóth, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer
Guillaume Fonteneau, Alexandra Redding, Hannah Hoag-Lee, et al.
Cancer Discovery (2022) Vol. 12, Iss. 8, pp. 1984-2005
Open Access | Times Cited: 42
KRAS mutant–driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer
Yuming Luo, Zhihua Li, Yao Kong, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 14
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top